sotigalimab
apexigen
['esophageal', 'sotigalimab', 'gastroesophageal', 'apexigen']
apexigen presents new data from a phase 2 trial evaluating its cd40 antibody, sotigalimab, in combination with neoadjuvant chemoradiation in patients with resectable esophageal and gastroesophageal junction cancers at esmo congress 2022 
?? ?? Get Profitable Stock Signal Alerts ?? ?? ?? ?? Sent Directly Via Text Message ?? ?? Click Link To Subscribe ????????